A blockchain-based solution is expected to provide more transparency in pharmaceutical supply chains in China
JD Medicine Open Tracing Solution is available on the JD Blockchain Open Platform and seeks to address concerns in China about the authenticity of medicines by supplying consumers with reliable and transparent tracing information. The tracing solution will cover every step of production, medical application, transportation, storage and sales of drugs. It has a friendly user interface and leverages IoT solutions to improve data collection efficiency.
The move comes after a handful of recent pharmaceutical safety incidents in China concerning substandard products, particularly when it comes to vaccines, which have been found to be expired or below safety standards in the past. As a result, Chinese consumers are increasingly concerned about the safety and origin of the medicine they consume.
In light of this, JD is teaming up with industry partners including medical software providers, industry associations, and smart hardware manufacturers to develop an entire IoT ecosystem of devices to promote medical traceability, raising standards and increasing transparency across the industry.
SEE ALSO: Blockchain for the banking industry: is the future already written?